Erick Araneda, MD
Interventional Cardiology · Grand Junction, CONPI 1154323228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Abbott at 27.0% of the total. Reporting peaked in 2021 at $1,805 and has fallen 99.1% since, to $17 in 2025. That places this record below the midpoint for interventional cardiology clinicians in CO, where the typical reported total is $6,820.
Across 160 payments — averaging $32.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Boston Scientific$1K
- Medtronic$1K
- Bard Peripheral Vascular, Inc.$360
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$216
- Shockwave Medical, Inc$143
- plus $718 from 15 others
What the payments were for
- Food & beverage$5,218100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 31 | $1,408 |
| Boston Scientific | 46 | $1,329 |
| Medtronic(3 entities) | 21 | $1,045 |
| Bard Peripheral Vascular, Inc. | 5 | $360 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $216 |
| Shockwave Medical, Inc | 2 | $143 |
| E.r. Squibb & Sons, L.L.C. | 9 | $130 |
| Novartis | 6 | $110 |
| Johnson & Johnson | 7 | $106 |
| Pfizer | 4 | $65 |
| AstraZeneca | 4 | $53 |
| Cardiovascular Systems Inc. | 1 | $40 |
| Biotronik Inc. | 2 | $39 |
| Chiesi USA, Inc. | 1 | $38 |
| Abiomed | 2 | $38 |
| Amgen | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Biosense Webster, Inc. | 1 | $15 |
| Terumo Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Confida$235
- Reveal LINQ$131
- Micra$119
- Assurity Pacemaker$118
- Resolute$113
- LUX-DX$112
How this compares
$5,218 in reported general payments places this provider in the 40th percentile of 111 interventional cardiology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Grand Junction
- Ehrin ArmstrongEnglewood$718K
- Gareth MorganAurora$536K
- Jamaluddin MolooAurora$272K
- Jenny Zablah AlabiAurora$269K
- Srinivas IyengarBoulder$254K
- Nima AghiliLakewood$220K
- Sridhar Sampath-KumarAurora$142K
- Matthew ZipseAurora$137K
- Jeffrey ParkAurora$132K
- Qaisar KhanThornton$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.